Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus | MicrobiomeTrials
Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-04-14Est. Completion: 2026-11-15
Enrollment target: 270 participants
Locations
Centrum Badań Klinicznych PI-House sp. z o.o., Gdansk, Poland
Diabetes Technology Center, Jagiellonian University Medical College, Krakow, Poland
NZOZ Neuromed, Kraśnik, Poland
NZOZ Neuromed, Lublin, Poland
Institute of Rural Health, Lublin, Poland
KO-MED Centra Kliniczne Lublin II, Lublin, Poland
BioResearch Group Sp. z o. o., Nadarzyn, Poland
Nbr Polska, Warsaw, Poland
Clinic of Internal Diseases, Endocrinology and Diabetology State Medical Institute MSWiA, Warsaw, Poland
ETG Warszawa, Warsaw, Poland
Baskent University Department of Endocrinology and Metabolism, Adana, Turkey (Türkiye)
Bakırköy Sadi Konuk Training and Research Hospital, Bakirkoy Istanbul, Turkey (Türkiye)
Başakşehir Çam and Sakura City Hospital, Basaksehir / Istanbul, Turkey (Türkiye)
Koç University Hospital, Istanbul, Turkey (Türkiye)
Cerrahpasa Medical School Department of Endocrinology, Istanbul, Turkey (Türkiye)
Medical Faculty of Istanbul University, Division of Endocrinology and Metabolism, Istanbul, Turkey (Türkiye)
Other microbiome trials you might be interested in